Therefore, in ADG, exploring the expression levels of CD47 and TIGIT and their prognostic relationships, as well as the relationship between pTERT mutations and MGMT methylation status and prognosis, may provide some valuable clues for the therapy of ADG. This evidence concerns the gene TIGIT and isolated congenital adermatoglyphia.